Reproductive Health in Men and Women With Vasculitis
1 other identifier
observational
467
1 country
1
Brief Summary
The purpose of this study is to learn about reproductive health, including fertility and pregnancies, in people with vasculitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 30, 2014
CompletedFirst Posted
Study publicly available on registry
June 26, 2014
CompletedJune 26, 2014
June 1, 2014
1.1 years
May 30, 2014
June 25, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
The rate of infertility with and without prior cyc.
1 year after the study is closed to enrollment
Secondary Outcomes (1)
The rate of pregnancy complications in pregnancies delivered before and after vasculitis diagnosis.
1 year after the study is closed to enrollment
Eligibility Criteria
All patients with vasculitis included in the VCRC Contact Registry were invited to participate. Data was included for all patients who provided a vasculitis diagnosis, estimated date of diagnosis, confirmed that the diagnosis was made by a rheumatologist, and reported having taken at least one appropriate anti-rheumatic medication. Other participants were excluded as the likelihood that they have a true vasculitis condition is low.
You may qualify if:
- Enrolled in VCRC Contact Registry
- Patient reported diagnosis of Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Polyarteritis Nodosa, Takayasu's Arteritis, Giant Cell Arteritis, Behcet's Disease, Kawasaki Disease, Henoch-Schoenlein Purpura, CNS or Drug-induced Vasculitis
- years of age or older
- English speaking
You may not qualify if:
- Inability to provide informed consent and complete survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of South Floridalead
- Duke Universitycollaborator
- Boston Universitycollaborator
- Data Management and Coordinating Center (DMCC)collaborator
Study Sites (1)
University of South Florida Data Management Coordinating Center
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Megan Clowse, MD, MPH
Duke University
- STUDY CHAIR
Amanda M. Terry, MA
USF College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2014
First Posted
June 26, 2014
Study Start
February 1, 2011
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
June 26, 2014
Record last verified: 2014-06